Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 000-50976 HURON CONSULTING GROUP INC. (Exact name of registrant as specified in its charter) Delaware 01-0666114 (State or other jurisdiction of incorpo ...

Financial Data and Key Metrics Changes - Revenues for Q3 2021 were $224 million, up 9.1% from $205.3 million in Q3 2020, driven by growth across all three operating segments [17] - Net income increased to $13.7 million or $0.64 per diluted share in Q3 2021, compared to $11.1 million or $0.50 per diluted share in Q3 2020 [17] - Adjusted EBITDA was $26.4 million in Q3 2021, representing 11.8% of revenues, compared to $23.6 million or 11.5% of revenues in Q3 2020 [17] Business Line Data and Key Metrics Changes - **Healthcare Segment**: Revenues grew 6.2% to $92.8 million, accounting for 42% of total company revenues [18][19] - **Business Advisory Segment**: Revenues increased by 5.9% to $70 million, representing 31% of total revenues, with growth driven by strategy and digital technology offerings [19] - **Education Segment**: Revenues rose 18% to $61.2 million, making up 27% of total revenues, driven by strong demand for student research and strategy offerings [21] Market Data and Key Metrics Changes - The company noted a robust pipeline in the healthcare and education sectors, with expectations for continued growth as pandemic-related challenges wane [5][12] - The tightening labor market is impacting hiring and wage pressures, but the company remains optimistic about its ability to attract talent due to its strong culture [42][43] Company Strategy and Development Direction - The company is focusing on core industry verticals such as healthcare, education, financial services, and energy, leveraging its technology capabilities to drive growth [46] - A strategic decision was made to divest the Life Sciences practice to concentrate resources on areas with better growth opportunities [11][28] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating current industry challenges and anticipates strong demand for services as the pandemic recedes [8][15] - The company narrowed its annual revenue guidance to $885 million to $905 million, with an adjusted EBITDA guidance range of 10.8% to 11.3% of revenues [27] Other Important Information - The company expects to finish the year with a leverage ratio below 2x adjusted EBITDA, with cash flow generated from operations in Q3 2021 amounting to $33.8 million [25][26] - DSO increased to 76 days in Q3 2021, up from 62 days in Q3 2020, but is expected to normalize to around 65 days [24] Q&A Session Summary Question: Sales conversion in Healthcare and Education - Management noted improved sales conversion in education and healthcare, with expectations for continued solid conversion of backlog [32][33] Question: Headcount growth drivers - The headcount growth was attributed to a mix of organic hiring, including new graduates and experienced hires across all segments [34][35] Question: Utilization rates and practices affecting them - Management indicated that lower utilization rates were due to excess capacity held in anticipation of market demand, which is now picking up [36][38] Question: Impact of tightening labor market on hiring - Management acknowledged the tightening labor market and wage pressures but stated it is manageable and not significantly affecting financial results [41][43] Question: Margin expansion outlook - Management expects a gradual return to pre-pandemic margin levels, with opportunities for margin enhancement through scale and efficiency improvements [51] Question: Travel expenses and their impact - Travel expenses are expected to ramp up as business activities increase, but most travel costs are billable to clients [52] Question: Impact of delayed project startups - The impact from delayed project startups due to the Delta variant was low-single digit millions, with expectations for recovery in Q4 [53] Question: Life Sciences divestiture proceeds - While specific sale price details were not disclosed, management indicated that the valuation was accretive based on revenue metrics [55]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Delaware 01-0666114 (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 000-50976 HURON CONSULTING GROUP INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction o ...

| --- | --- | --- | --- | --- | --- | --- | --- | |-----------------------|-----------------------------------------|-------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | INVESTOR PRESENTATION | | | | | | | | | Sidoti | & Company Fall 2021 Investor Conference | | | | | | | | | September 22, 2021 | | | | | | | | | | | | | | | | | | | | | | | | | Forward-looking Statements 2 Statements in this press release that are not his ...

Financial Data and Key Metrics Changes - Revenues for Q2 2021 were $230.1 million, up 5.6% from $217.9 million in Q2 2020, driven by growth in Healthcare and Business Advisory segments, partially offset by a decline in Education segment revenues [17] - Net income was $12.8 million or $0.59 per diluted share in Q2 2021, compared to $13.6 million or $0.61 per diluted share in the same quarter in the prior year [18] - Adjusted EBITDA was $25.6 million in Q2 2021, or 11.1% of revenues, compared to $27.5 million or 12.6% of revenues in Q2 2020 [18] Business Line Data and Key Metrics Changes - Healthcare segment revenues grew 19% year-over-year to $101.4 million, reflecting strong recovery and demand for performance improvement and revenue cycle managed services [7][19] - Business Advisory segment revenues were flat year-over-year at $70.9 million, with double-digit growth in digital technology and analytics offset by declines in distressed Advisory and Life Sciences businesses [9][21] - Education segment revenues declined 7% year-over-year to $57.9 million, but grew 14% sequentially from Q1 2021, driven by demand in research, strategy, and operations [11][23] Market Data and Key Metrics Changes - The Healthcare segment generated 44% of total company revenues in Q2 2021, while Business Advisory and Education segments contributed 31% and 25%, respectively [19][21][23] - The company anticipates continued growth in Healthcare and Education segments, supported by a recovering market and increased demand for services [15][29] Company Strategy and Development Direction - The company is focused on leveraging its investments in digital transformation and technology capabilities to enhance service offerings across all segments [10][15] - The management emphasizes the importance of retaining talent during the pandemic to sustain growth and improve margins as demand stabilizes [13] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in the recovery trajectory of Healthcare and Education segments, expecting strong demand for services as clients adapt to post-pandemic challenges [6][15] - The company raised its annual revenue guidance to a range of $875 million to $905 million, reflecting anticipated recovery in demand [14][29] Other Important Information - The company reported a DSO (Days Sales Outstanding) of 73 days for Q2 2021, an increase from 64 days in Q1 2021, with expectations to normalize around 60 days [26] - Total debt was $268 million, with a leverage ratio of approximately 2.8x adjusted EBITDA as of June 30, 2021 [27] Q&A Session Summary Question: What is in the pipeline for Healthcare performance improvement? - Management indicated a consistent portfolio of opportunities, with expectations for growth driven by financial pressures in the healthcare industry [31] Question: Can you discuss the revenue and earnings cadence for the rest of the year? - Management noted that the acceleration in Q2 was ahead of expectations, and while they do not anticipate a deceleration, they expect a more stable run rate for the remainder of the year [34][35] Question: What is the hiring environment and employee retention like? - Management reported a competitive hiring environment, particularly in technology areas, with turnover rates higher than last year but consistent with historical trends [36][37] Question: Can you provide details on the new healthcare managed services employees? - Management explained the history of the managed services offering and the recent onboarding of 300 employees, emphasizing the potential for revenue growth from this segment [41][42] Question: What is the outlook for sequential revenue growth in Healthcare and Education? - Management confirmed expectations for sequential revenue improvement in both segments, driven by recovering demand and ongoing projects [54][56]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 000-50976 HURON CONSULTING GROUP INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organi ...

Huron Consulting Group Inc. (NASDAQ:HURN) Q1 2021 Earnings Conference Call May 4, 2021 5:00 PM ET Company Participants Jim Roth - Chief Executive Officer John Kelly - Chief Financial Officer Mark Hussey - President and Chief Operating Officer Conference Call Participants Tobey Sommer - Truist Securities Andrew Nicholas - William Blair Kevin Steinke - Barrington Josh Vogel - Sidoti Operator Good afternoon, ladies and gentlemen, and welcome to Huron Consulting Group's webcast to discuss financial results for ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 000-50976 HURON CONSULTING GROUP INC. (Exact name of registrant as specified in its charter) Indicate by check mark whether the registrant (1) has ...

Huron Consulting Group Inc. (NASDAQ:HURN) Q4 2020 Earnings Conference Call February 23, 2021 5:00 PM ET Company Participants Jim Roth - Chief Executive Officer John Kelly - Executive Vice President, Chief Financial Officer, Treasurer Mark Hussey - President, Chief Operating Officer Conference Call Participants Andrew Nicholas - William Blair Kevin Steinke - Barrington Research Tobey Sommer - Truist Securities Bill Sutherland - The Benchmark Company Josh Vogel - Sidoti and Company Operator Good afternoon, la ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 000-50976 HURON CONSULTING GROUP INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Mark One) Delaware 01-0666114 (IRS Employer Identification Number) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHAN ...